CYPB - Cypress BioScience Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : CYPB - Cypress BioScience

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Jay Lowe who wrote (214)	5/18/1998 9:59:00 PM
From: muddphudd	Read Replies (2) of 586

By the way, I also asked Dr. Blank what direction their research going in trying to elucidate the mechanism by which the Prosorba column helps patients with RA. Surprisingly, they have done nothing with the columns themselves. What I mean is that after the patient's serum is passed over the column and returned to the patient, whatever was separated from the serum is bound on the column. I asked whether they have tried to figure out whether there is anything unique to RA patients bound to the column versus control non-RA patients. They are not even looking at that! They are trying to work with the actual blood of RA patients first. She said they have kept all the column in -80 degrees for future study. Personally, I think this is a mistake. They should try, at the very least, to see if there is a particular pattern of antibodies that is secluded on the column from RA patients' blood. Since they have no leads at this time, another approach may help, no? Well, that's it. CYPB is holding very strong at 3 1/8. Low volume still. Need more exposure. Regards.

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next